The trajectory of copyright's flagship drug presents a nuanced case for observers in the medicinal sector. While initially a phenomenal success, producing huge profits, the intellectual property end and the subsequent https://knockoff503958.blogadvize.com/50332676/the-little-copyright-and-the-pharmaceutical-industry-a-risky-play